Literature DB >> 26258490

Preinjury Emotional-Behavioral Functioning of Children With Lingering Problems After Mild Traumatic Brain Injury.

Robin L Peterson1, Amy K Connery1, David A Baker1, Michael W Kirkwood1.   

Abstract

This study aimed to characterize preinjury emotional-behavioral functioning in pediatric patients with lingering problems after mild traumatic brain injury (TBI). The clinical case series design included 278 patients 8-17 years old. Parents retrospectively rated children's preinjury emotional-behavioral functioning on a broadband questionnaire. The rate of clinically significant preinjury anxiety was elevated compared with national norms. The number of previous TBIs was associated with clinically significant preinjury externalizing problems, suggesting a link between externalizing disorders and mild TBI exposure. Premorbid emotional-behavioral difficulties may play an important role in the establishment or maintenance of lingering symptoms after pediatric mild TBI.

Entities:  

Mesh:

Year:  2015        PMID: 26258490     DOI: 10.1176/appi.neuropsych.14120373

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  3 in total

Review 1.  Depression and Depressive Symptoms in Pediatric Traumatic Brain Injury: A Scoping Review.

Authors:  Christianne Laliberté Durish; Rosemary S Pereverseff; Keith O Yeates
Journal:  J Head Trauma Rehabil       Date:  2018 May/Jun       Impact factor: 2.710

2.  Psychological Factors Associated with Delayed Symptom Resolution in Children with Concussion.

Authors:  Joseph A Grubenhoff; Dustin Currie; R Dawn Comstock; Elizabeth Juarez-Colunga; Lalit Bajaj; Michael W Kirkwood
Journal:  J Pediatr       Date:  2016-04-11       Impact factor: 4.406

Review 3.  Pediatric Traumatic Brain Injury and Autism: Elucidating Shared Mechanisms.

Authors:  Rahul Singh; Ryan C Turner; Linda Nguyen; Kartik Motwani; Michelle Swatek; Brandon P Lucke-Wold
Journal:  Behav Neurol       Date:  2016-12-15       Impact factor: 3.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.